StockData
Nkarta, Inc. logo

Nkarta, Inc. (NKTX) stock

NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$1.25+0.04 (+3.31%)

Close on Nov 17, 2026Market cap $89.53MP/E –Yield 0.00%

Nkarta enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Nkarta's enterprise value was -$72.94M on Nov 11, 2026, against -$142.68M a year earlier. Over the last 5 years it ranged from -$219.16M to $369.90M, with a median of -$103.56M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$72.94M–
2025Dec 31, 2025-$145.64M–
2024Dec 31, 2024-$129.40M-372.2%
2023Dec 29, 2023$47.53M–
2022Dec 30, 2022-$155.12M-163.1%
2021Dec 31, 2021$245.77M-85.3%
2020Dec 31, 2020$1.67B–

More Nkarta figures

See a number that looks wrong?